DJIA 16,614.81 215.14 1.31%
NASDAQ 4,419.48 103.40 2.40%
S&P 500 1,941.28 37.27 1.96%
market minute promo


company name or ticker

Monday Sector Laggards: Drugs, Manufacturing Stocks

Why Clovis Oncology Inc. Shares Crashed

Is this meaningful or just another movement?

Morning Market Losers

ASCO Showdown: AstraZeneca vs. Clovis Oncology

The annual meeting brings together some of the world's most exciting emerging cancer treatments, and after only a day AztraZenica and Clovis are making waves as the compete in the lung cancer market.

Benzinga's Top #PreMarket Losers

Clovis' Lung Cancer Bravado Falls Flat With New Diabetes Revelation

ASCO '14: What's on Tap for Saturday

Clovis Oncology (CLVS) Falls: Stock Goes Down 9.2% - Tale of the Tape

Clovis Gets Breakthrough Therapy Designation - Analyst Blog

Clovis Snags FDA Designation: What's Next?

The coveted breakthrough designation comes through for CO-1686.
See More Articles...